Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
Press release announcing that The Main Street Pharmacy Access Act has advanced in the Ways and Means Committee. AMCP thanks committee members for their leadership and recognizes the role AMCP members played in advocating directly with lawmakers to help move this issue forward. This legislation is an important step toward improving access to pharmacist-provided care for Medicare patients — in states that already authorize pharmacists to perform these services.
In this video, Shelby Cole shares her experience living with narcolepsy type one with cataplexy, a chronic neurological disorder that affects the body’s ability to regulate sleep and wake cycles.
A roundup of Prime's award-winning presentations and insights at AMCP 2026 in Nashville, Tennessee
On April 21, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a Status Update on the Medicare GLP-1 BRIDGE Demo and BALANCE Model in Part D for CY 2027.
The AMCP Research Institute (ARI) announced the launch of Cardiometabolic Health Real-world Outcomes & Management Evaluation (CHROME), a multisite research initiative designed to evaluate the effectiveness, structure, and economic impact of comprehensive cardiometabolic care models such as Cardiometabolic Centers of Excellence (CoEs) and dedicated obesity clinics. This collaborative research initiative is supported by Lilly and will generate real-world evidence intended to help inform best-practice recommendations and implementation guidance to support scalable cardiometabolic care nationwide.
The Academy of Managed Care Pharmacy (AMCP) has selected Chelsey Sparks, PharmD candidate at Lipscomb University in Nashville, TN, as its 2026–2027 Executive Fellow in Health Care Association Leadership. This year-long program offers a comprehensive, in-depth learning experience for pharmacists interested in health care association leadership or managed care pharmacy.
On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate Medicare coverage for certain FDA-designated Breakthrough Devices by aligning evidence requirements and coverage decisions earlier in development.
